VMP 39111211000001103

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Fluticasone 125micrograms/dose inhaler CFC free
BNF code 0302000N0AABABA
Virtual Therapeutic Moiety Fluticasone
Date identifier became valid 21 Oct 2020
Previous product identifier 320614005
Basis of preferred name rINN - Recommended International Non-proprietary
Date of name applicability 15 Aug 2006
Previous name Fluticasone 125micrograms/actuation inhaler CFC free
Basis of previous name rINN - Recommended International Non-proprietary
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units dose
Unit dose unit of measure dose
Virtual Product Ingredient
Ingredient Fluticasone propionate
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 125.000
Strength value numerator unit microgram
Strength value denominator 1.000
Strength value denominator unit dose
Ontology Drug Form & Route
Form & Route pressurizedinhalation.inhalation
Dose Form
Formulation Pressurised inhalation
Drug Route
Route Inhalation
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Flixotide 125micrograms/dose Evohaler (GlaxoSmithKline UK Ltd)
Flixotide 125micrograms/dose Evohaler (Lexon (UK) Ltd)
Flixotide 125micrograms/dose Evohaler (Necessity Supplies Ltd)
Flixotide 125micrograms/dose Evohaler (Sigma Pharmaceuticals Plc)
Virtual Medicinal Product Packs
Fluticasone 125micrograms/dose inhaler CFC free 120 dose
Fluticasone 125micrograms/dose inhaler CFC free 60 dose

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback